The Society for Maternal-Fetal Medicine supports the clinical practice of maternal-fetal medicine by providing education, promoting research, and engaging in advocacy to optimize the health of high-risk pregnant women and their babies.
Looking for a job in the field of maternal-fetal medicine? Check out the Career Opportunities page at SMFM!
SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy
In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.
Read More
SMFM Consult Series #60: Management of pregnancies resulting from IVF
This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.
Read More
This Consult has been endorsed by the American College of Obstetricians and Gynecologists (ACOG) and replaces the Society for Maternal-Fetal Medicine's (SMFM) Statement #4, Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016.
Read More
ICD-10-CM Diagnosis Codes for 2022
February 8th 2022Effective each year on October 1, additions, deletions, and updates to the ICD-10-CM code set are published. This year, no significant changes were made to Chapter 15, the obstetrics chapter. However, there are a few new codes that could affect the practice of maternal-fetal medicine.
Read More
SMFM Consult Series #56: Hepatitis C in pregnancy: updated guidelines
SMFM Consult Series #56: Hepatitis C in pregnancy: updated screening, treatment, and management guidelines.
Read More
Register for SMFM's 42nd Annual Pregnancy Meeting
September 13th 2021Registration is now open for the Society for Maternal-Fetal Medicine's (SMFM) 42nd Annual Pregnancy Meeting, to be held from January 31 to February 5, 2022, at the Gaylord Palms Resort and Convention Center near Orlando, Florida.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy
Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.
Read More
A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.
Read More